MX9201809A - N-hidroxi-n-(3-(fenil 2 substituido)prop-2-enil)urea y tiourea y formulacion farmaceutica que las contiene. - Google Patents

N-hidroxi-n-(3-(fenil 2 substituido)prop-2-enil)urea y tiourea y formulacion farmaceutica que las contiene.

Info

Publication number
MX9201809A
MX9201809A MX9201809A MX9201809A MX9201809A MX 9201809 A MX9201809 A MX 9201809A MX 9201809 A MX9201809 A MX 9201809A MX 9201809 A MX9201809 A MX 9201809A MX 9201809 A MX9201809 A MX 9201809A
Authority
MX
Mexico
Prior art keywords
prop
urea
hydroxy
substituted
enil
Prior art date
Application number
MX9201809A
Other languages
English (en)
Inventor
Tulio Suarez
Gary Alan Hite
Edward David Mihelich
David Wells Snyder
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of MX9201809A publication Critical patent/MX9201809A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C323/39—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton at least one of the nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom
    • C07C323/43—Y being a hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C335/00—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C335/40—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of thiourea or isothiourea groups further bound to other hetero atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/64—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups singly-bound to oxygen atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pulmonology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Esta invención se refiere a N-hidroxi-N-[3-(fenil2-sustituído)prop-2-enil]urea s y tioureas, a formulados que contienen estos compuestos y a métodos de uso de estos compuestos como agentes inhibidores de la 5-lipoxi-genasa.
MX9201809A 1991-04-23 1992-04-20 N-hidroxi-n-(3-(fenil 2 substituido)prop-2-enil)urea y tiourea y formulacion farmaceutica que las contiene. MX9201809A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/690,131 US5130485A (en) 1991-04-23 1991-04-23 N-hydroxy-N-(3-(2-substituted phenyl)prop-2-enyl)ureas and thioureas useful as 5-lipoxygenase inhibiting agents

Publications (1)

Publication Number Publication Date
MX9201809A true MX9201809A (es) 1994-05-31

Family

ID=24771221

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9201809A MX9201809A (es) 1991-04-23 1992-04-20 N-hidroxi-n-(3-(fenil 2 substituido)prop-2-enil)urea y tiourea y formulacion farmaceutica que las contiene.

Country Status (19)

Country Link
US (1) US5130485A (es)
EP (1) EP0510947A1 (es)
JP (1) JPH05148218A (es)
KR (1) KR920019739A (es)
CN (1) CN1066060A (es)
AU (1) AU647911B2 (es)
BR (1) BR9201451A (es)
CA (1) CA2066509A1 (es)
CS (1) CS119592A3 (es)
FI (1) FI921785A7 (es)
HU (1) HU209794B (es)
IE (1) IE921280A1 (es)
IL (1) IL101624A0 (es)
MX (1) MX9201809A (es)
NO (1) NO921529L (es)
NZ (1) NZ242427A (es)
TW (1) TW215081B (es)
YU (1) YU42592A (es)
ZA (1) ZA922872B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5283361A (en) * 1991-04-23 1994-02-01 Eli Lilly And Company N-hydroxy-N-[3-[2-(halophenylthio)phenyl]prop-2-enyl]ureas as lipoxygenase inhibitors
US5288743A (en) * 1992-11-20 1994-02-22 Abbott Laboratories Indole carboxylate derivatives which inhibit leukotriene biosynthesis
TW448144B (en) * 1993-08-19 2001-08-01 Pfizer Phenoxyphenyl cyclopentenyl hydroxyureas
US5891460A (en) * 1995-06-07 1999-04-06 University Of Southern California University Park Campus Method for reducing or preventing post-surgical adhesion formation using ketotifen and analogs thereof
NZ624963A (en) 2009-04-29 2016-07-29 Amarin Pharmaceuticals Ie Ltd Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same
US11724991B1 (en) * 2023-01-06 2023-08-15 King Faisal University Selective 5-LO inhibitors for the treatment of bronchial asthma

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT82200B (pt) * 1985-03-16 1990-02-08 Wellcome Found Processo para a preparacao de novos derivados do acido hidroxamico e de composicoes farmaceuticas que os contem
IE59397B1 (en) * 1985-03-16 1994-02-23 Wellcome Found New aryl derivatives
GB8619593D0 (en) * 1986-08-12 1986-09-24 Roussel Lab Ltd Chemical compounds
US4897422A (en) * 1987-02-10 1990-01-30 Abbott Laboratories Lipoxygenase inhibiting compounds
DE3882732T2 (de) * 1987-02-10 1993-12-02 Abbott Lab Indol, Benzofuran, Benzothiophen enthaltende, Lipoxygenase hemmende Verbindungen.
CA1336099C (en) * 1987-04-24 1995-06-27 James B. Summers, Jr. Urea based lipoxygenase compounds
CA2009201A1 (en) * 1989-02-03 1990-08-03 William Paul Jackson Anti-inflammatory aryl derivatives
WO1990012008A1 (en) * 1989-03-30 1990-10-18 Abbott Laboratories Urea based lipoxygenase inhibiting compounds

Also Published As

Publication number Publication date
CN1066060A (zh) 1992-11-11
EP0510947A1 (en) 1992-10-28
CA2066509A1 (en) 1992-10-24
FI921785A0 (fi) 1992-04-22
AU1501692A (en) 1992-10-29
NO921529D0 (no) 1992-04-21
ZA922872B (en) 1993-10-21
NZ242427A (en) 1993-11-25
BR9201451A (pt) 1992-12-01
IE921280A1 (en) 1992-11-04
CS119592A3 (en) 1992-12-16
TW215081B (es) 1993-10-21
HU9201342D0 (en) 1992-07-28
US5130485A (en) 1992-07-14
FI921785A7 (fi) 1992-10-24
JPH05148218A (ja) 1993-06-15
IL101624A0 (en) 1992-12-30
NO921529L (no) 1992-10-26
YU42592A (sh) 1995-01-31
AU647911B2 (en) 1994-03-31
HUT61978A (en) 1993-03-29
KR920019739A (ko) 1992-11-19
HU209794B (en) 1994-11-28

Similar Documents

Publication Publication Date Title
UA26097A1 (uk) Триазиhові похідhі, що мають гербіцидhу активhість, спосіб їх одержаhhя та гербіцидhа композиція hа їх осhові
FI931708A0 (fi) Herbicida substituerade aryl-haloalkylpyrazoler
DE69324859D1 (de) Verwendung von Lipid-gebundener Glykoaminoglykanen zur Behandlung der rheumatoider Arthritis
MX9203644A (es) Derivados substituidos de la 3-aril-pirrolidin-2,4-diona y procedimiento para su obtencion.
BG104544A (en) Novel acylguanadine derivatives as inhibitors of bone resorption and as vitronectin receptor antagonists
NO952207L (no) Anvendelse av 2-amino-6-A-propylamino-4,5,6,7-tetrahydrobenzotiazol (pramipexol) som et antidepresivt legemiddel
ES2174298T3 (es) Derivados de aminotiazol, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
ES2134801T3 (es) Monohidrato de hidrocloruro de tiagabina cristalina, su preparacion y su uso.
ES2195397T3 (es) Quinazolin-2,4-dionas sustituidas en posicion 7 utiles como agentes antibacterianos.
NO923265D0 (no) Benzol(f)quinolinoner
IT1228288B (it) Composti ad attivita' antiserotoninica
FI911863A7 (fi) Metyleenidifosfonihappoyhdiste ja tulehdusta estävä aine, joka sisältä ä tätä yhdistettä tehokomponenttina
BR9806805A (pt) Mistura sólida, e, processos para controlar o crescimento de plantas indesejáveis e para preparar formulações de herbicidas.
GR1001597B (el) Νέα βιολογικώς δραστικά παράγωγα εμπουρναμενίνης, φαρμακευτικές συν?έσεις οι οποίες περιέχουν αυτά και μέ?οδος δια την παρασκευή αυτών.
MX9201809A (es) N-hidroxi-n-(3-(fenil 2 substituido)prop-2-enil)urea y tiourea y formulacion farmaceutica que las contiene.
GR1001511B (el) Στεροειδείς συν?έσεις.
YU215190A (sh) Imidazolovi fungicidi
BR8902892A (pt) Processo para a preparacao de hidrazinas substituidas e composicao inseticida
SE8600658D0 (sv) Novel composition of matter
ES2082074T3 (es) 1,3-difenil-2-propin-1-onas.
FI945164A0 (fi) Biologisesti aktiivisesti ureidojohdannaiset, jotka ovat käyttökelpoisia antimetastaattisina aineina
ES542061A0 (es) Un procedimiento para la preparacion de (r)-4-amino-n-(1-fe-niletil)benzamida,(s)-4-amino-n-(1-feniletil)benzamida,o unasal de las mismas
ATE69220T1 (de) Sechsgliedrige heterocyclische derivate von n'substituiertenn,n'-diacylhydrazinen.
ES2155187T3 (es) Antagonistas biciclicos de taquicinas, preparacion de estos antagonistas y su utilizacion en compuestos farmaceuticos.
MX9204815A (es) Hexahidrobenzo[f]quinolinonas y formulacion farmaceutica que las comprende.